Visipaque

Visipaque (Iodixanol) is a non-ionic, iso-osmolar contrast agent used in radiology for clear imaging of blood vessels and organs. It enhances visibility during CT scans, MRIs, and angiographic procedures. Suitable for intraarterial, intravenous, and intrathecal use. Provides high contrast with low risk of adverse reactions compared to ionic agents.

Visipaque (Iodixanol) is primarily used as a contrast medium to improve the visibility of internal body structures during diagnostic imaging procedures. It helps radiologists visualize blood vessels, organs, and tissues more clearly in CT scans, MRIs, and angiograms. Commonly used for procedures like coronary angiography, CT angiography, and myelography. Its iso-osmolar properties reduce the risk of discomfort or complications during imaging.

Visipaque (Iodixanol) works by temporarily increasing the density of tissues or fluids it contacts, making them appear brighter on imaging scans. This enhanced visibility helps healthcare providers identify abnormalities such as blockages, tumors, or structural issues. Patients may experience a warm sensation or mild discomfort during administration, which typically resolves quickly. The contrast agent is designed to be well-tolerated with minimal risk of side effects.

Visipaque (Iodixanol) should only be administered by trained healthcare professionals in a clinical setting equipped for imaging procedures. Patients with a history of severe allergic reactions to contrast agents or iodine should inform their provider before use. Adequate hydration before and after the procedure is recommended to support kidney function. Pregnant or breastfeeding individuals should consult their doctor prior to use.

Visipaque (Iodixanol) may interact with medications that affect kidney function, such as certain diuretics or nonsteroidal anti-inflammatory drugs (NSAIDs). Patients taking metformin should discuss temporary discontinuation with their doctor due to the risk of lactic acidosis. Alcohol and other substances do not typically interact with the contrast agent but may affect overall procedure safety. Always disclose all medications and conditions to your healthcare provider.